Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for chronic allograft nephropathy in pediatric kidney transplant recipients
ISRCTN19419571Phase 4Completed
- Sponsor
- Sectorial Fund for Health Research
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Chronic Allograft Kidney Disease (CKaD) comparing Eplerenone with Placebo (2 arms). Primary endpoint: Change in glomerular filtration rate at 24 months. Started Jun 2009; status: completed.
02
Drugs
eplerenone
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on ISRCTN19419571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN19419571.